Gline Matthew
Gline Matthew, CEO, reported a transaction classified as withholding at Roivant Sciences Ltd. involving 34638.000000 shares for an estimated $1161412.14. Reported holdings after the transaction were 16549136.000000 shares. A 10b5-1 reference was not detected in the stored filing text.
- Trade date
- Oct 16, 2026
- Filing date
- Oct 20, 2026
How reported position traded is calculated
Calculated only for code-P purchases and code-S sales.
Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.
ROIV price since this filing
Daily closing prices, with the filing date and available return windowsTransaction facts
Stored Form 4 columns with their raw values
- Type
- withholding Code F
- Identifier
- 0001635088-26-000113 Common Shares
- Transaction date
- Oct 16, 2026 Filed Oct 20, 2026, 09:41 PM · 4d delay
- Shares
- 34,638 sh $33.53 per share
- Estimated value
- -$1.16M Computed from shares × price
- Holdings after
- 16,549,136 sh Direct
Filing signal explanations
Badges describe filing facts only — not predictions.
-16 points
Compact filing score computed from stored Form 4 facts. Version v1.
This filing has a negative filing-only score. It may be less informative as an insider-activity signal and needs extra context.
How this score is calculated
- direct_ownership+6 points
direct_or_indirect_ownership = D
Direct ownership reports the insider's personal stake. - tax_withholding-22 points
transaction_code = F
Tax withholding on vesting shares is mechanical.
Signed filing-only points, not a probability or expected return. Version v1.
Reported relationships & other filings
Form 4 relationship flags and nearby filing context
CEO
- F1
Represents the "net settlement" by the Issuer of performance restricted stock units ("PSUs"), previously granted to the reporting person on July 26, 2024, in order to satisfy applicable tax withholdin…
0 other transactions
0 recent txs